Table 1.
A. AsPC-1 | B. BxPC-3 | ||
---|---|---|---|
Erlotinib (µM) | CI | Erlotinib (µM) | CI |
0.001 | 0.43 | 0.001 | 0.88 |
0.01 | 0.42 | 0.01 | 0.84 |
0.1 | 0.5 | 0.1 | 0.91 |
1 | 0.62 | 1 | 0.8 |
10 | 1.4 | 10 | 1.1 |
A. AsPC-1 | B. BxPC-3 | ||
---|---|---|---|
Erlotinib (µM) | CI | Erlotinib (µM) | CI |
0.001 | 0.43 | 0.001 | 0.88 |
0.01 | 0.42 | 0.01 | 0.84 |
0.1 | 0.5 | 0.1 | 0.91 |
1 | 0.62 | 1 | 0.8 |
10 | 1.4 | 10 | 1.1 |